NASDAQ: APGEApogee Therapeutics Inc Stock Ownership - Who owns Apogee Therapeutics?
Insider buying vs selling
Have Apogee Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC | Director | 2023-07-13 | 892,529 | $17.00 | $15.17MBuy |
| Fairmount Funds Management LLC | Director | 2023-07-13 | 1,992,734 | $17.00 | $33.88MBuy |
| Fairmount Funds Management LLC | Director | 2023-07-13 | 55,913 | $17.00 | $950.52kBuy |
| Nimish P. Shah | Director | 2023-07-13 | 1,750,000 | $17.00 | $29.75MBuy |
APGE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when APGE insiders and whales buy or sell their stock.
APGE Shareholders
What type of owners hold Apogee Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vr Adviser LLC | 16.77% | 8,493,321 | $460.25M | Institution |
| Fmr LLC | 9.91% | 5,018,880 | $271.97M | Institution |
| Fairmount Funds Management LLC | 5.81% | 2,941,176 | $159.38M | Institution |
| Deep Track Capital LP | 4.59% | 2,323,456 | $125.91M | Institution |
| Fairmount Funds Management LLC | 4.25% | 2,150,979 | $116.56M | Insider |
| Rtw Investments LP | 4.23% | 2,142,591 | $116.11M | Institution |
| Ra Capital Management LP | 3.90% | 1,977,901 | $107.18M | Institution |
| Perceptive Advisors LLC | 3.61% | 1,827,901 | $99.05M | Institution |
| Nimish P. Shah | 3.45% | 1,750,000 | $94.83M | Insider |
| Blackrock Inc | 3.25% | 1,644,037 | $89.09M | Institution |
APGE vs Biotech Stocks
Apogee Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.